Inhiprot
InhiProt is a start-up biotech company that aims to develop novel treatments for multiple myeloma, an incurable cancer of bone marrow.
Call 2020
The 2020 Call for Application is now close. Stay tuned for the 2021 Call
See also
@YeiAccelerator
Newsletter
Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)